四环医药(00460.HK)建议分拆轩竹生物联交所主板上市

阿斯达克财经
13 Nov 2024

四环医药(00460.HK) 公布,建议分拆轩竹生物于联交所主板上市,并已取得联交所确认可以进行建议分拆。同时,公司向阳光人寿进一步收购轩竹生物3.6177%股权,总代价3.08亿人民币。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-11-12 16:25。)

AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10